The DOI matches its Crossref record; 537 of the 537 references it cites were found in a registry or an index.
Rho GTPase signaling in cancer progression and dissemination
Open accessAbstract
Rho GTPases are a family of small G proteins that regulate a wide array of cellular processes related to their key roles controlling the cytoskeleton. Cancer is a multistep disease caused by the accumulation of genetic mutations and epigenetic alterations, from the initial stages of cancer development when cells in normal tissues undergo transformation, to the acquisition of invasive and metastatic traits, responsible for a large number of cancer related deaths. In this review, we discuss the role of Rho GTPase signaling in cancer in every step of disease progression. Rho GTPases contribute to tumor initiation and progression, by regulating proliferation and apoptosis, but also metabolism, senescence, and cancer cell stemness. Rho GTPases play a major role in cell migration and in the metastatic process. They are also involved in interactions with the tumor microenvironment and regulate inflammation, contributing to cancer progression. After years of intensive research, we highlight the importance of relevant models in the Rho GTPase field, and we reflect on the therapeutic opportunities arising for cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–537 of 537
Tovo, L. F. R., Belfort, F. A., & Sanches, J. A. (2005) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302005000100010 · Cited by 66
Chaudhuri, P. K., Pan, C. Q., Low, B. C., & Lim, C. T. (2016) · Scientific Reports · doi:10.1038/srep19672 · Cited by 66
Acute compressive stress activates RHO/ROCK-mediated cellular processes
Boyle, S. T., Kular, J., Nobis, M., Ruszkiewicz, A. R., Timpson, P., & Samuel, M. S. (2018) · Small GTPases · doi:10.1080/21541248.2017.1413496 · Cited by 66
The curious origins of angioimmunoblastic T-cell lymphoma
Cortés, J. R., & Palomero, T. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000261 · Cited by 65
Targeting Ras-Driven Cancer Cell Survival and Invasion through Selective Inhibition of DOCK1
Tajiri, H., Uruno, T., Shirai, T., Takaya, D., Matsunaga, S., Setoyama, D., Watanabe, M., Kukimoto‐Niino, M., Oisaki, K., Ushijima, M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.016 · Cited by 65
Chenette, E. J., Abo, A., & Der, C. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411300200 · Cited by 64
Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases
Oprea, T. I., Sklar, L. A., Agola, J. O., Guo, Y., Silberberg, M., Roxby, J., Vestling, A., Romero, E., Surviladze, Z., Murray-Krezan, C. M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142182 · Cited by 64
Gordon, B. S., Kazi, A. A., Coleman, C. S., Dennis, M. D., Chau, V., Jefferson, L. S., & Kimball, S. R. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.035 · Cited by 63
A novel small-molecule MRCK inhibitor blocks cancer cell invasion
Unbekandt, M., Croft, D. R., Crighton, D., Mezna, M., McArthur, D. R., McConnell, P., Schüttelkopf, A. W., Belshaw, S., Pannifer, A., Sime, M., et al. (2014) · Cell Communication and Signaling · doi:10.1186/s12964-014-0054-x · Cited by 62
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis
Chatterjee, A., Ghosh, J., Ramdas, B., Mali, R. S., Martin, H., Kobayashi, M., Vemula, S., Canela, V. H., Waskow, E., Visconte, V., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.039 · Cited by 61
CDC42 Inhibition Suppresses Progression of Incipient Intestinal Tumors
Sakamori, R., Yu, S., Zhang, X., Hoffman, A., Sun, J., Das, S., Vedula, P., Li, G., Fu, J., Walker, F., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0267 · Cited by 60
Arulanandam, R., Vultur, A., Cao, J., Carefoot, E., Elliott, B. E., Truesdell, P. F., Larue, L., Feracci, H., & Raptis, L. H. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0469 · Cited by 60
Atypical Rho GTPases of the RhoBTB Subfamily: Roles in Vesicle Trafficking and Tumorigenesis
Ji, W., & Rivero, F. (2016) · Cells · doi:10.3390/cells5020028 · Cited by 60
Wermke, M., Camgöz, A., Paszkowski‐Rogacz, M., Thieme, S., Bonin, M. V., Dahl, A., Platzbecker, U., Theis, M., Ehninger, G., Brenner, S., et al. (2015) · Blood · doi:10.1182/blood-2014-07-590646 · Cited by 59
Maldonado, M., Luu, R. J., Ramos, M. E. P., & Nam, J. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.07.009 · Cited by 59
Mohan, A. S., Dean, K. M., Isogai, T., Kasitinon, S. Y., Murali, V. S., Roudot, P., Groisman, A., Reed, D. K., Welf, E. S., Han, S. J., et al. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.007 · Cited by 59
Differential interaction and activation of Rho family GTPases by p210bcr-abl and p190bcr-abl
Harnois, T., Constantin, B., Rioux, A., Grenioux, E., Kitzis, A., & Bourmeyster, N. (2003) · Oncogene · doi:10.1038/sj.onc.1206626 · Cited by 58
Zhang, C., Liu, Q., Li, M., Lin, S., Peng, Y., Wu, D., Li, T. Y., Fu, Q., Jia, W., Wang, X., et al. (2015) · Cell Research · doi:10.1038/cr.2015.90 · Cited by 57
Rho GEFs and Cancer: Linking Gene Expression and Metastatic Dissemination
Barrio‐Real, L., & Kazanietz, M. G. (2012) · Science Signaling · doi:10.1126/scisignal.2003543 · Cited by 57
Relja, B. (2010) · International Journal of Oncology · doi:10.3892/ijo.2010.892 · Cited by 57
Guo, F., & Zheng, Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1426-1438.2004 · Cited by 57
Suppression of RAC1-driven malignant melanoma by group A PAK inhibitors
Araiza‐Olivera, D., Feng, Y., Semenova, G., Prudnikova, T. Y., Rhodes, J., & Chernoff, J. (2017) · Oncogene · doi:10.1038/onc.2017.400 · Cited by 57
Sato, N., Fukui, T., Taniguchi, T., Yokoyama, T., Kondo, M., Nagasaka, T., Goto, Y., Gao, W., Ueda, Y., Yokoi, K., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22328 · Cited by 56
Mechanism of cell rear retraction in migrating cells
Cramer, L. P. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.05.001 · Cited by 56
Bolado‐Carrancio, A., Rukhlenko, O. S., Nikonova, E. V., Tsyganov, M. A., Wheeler, A. P., García-Muñoz, A., Kölch, W., von Kriegsheim, A., & Kholodenko, B. Ν. (2020) · eLife · doi:10.7554/elife.58165 · Cited by 56
Xu, L. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.775 · Cited by 55
Talamillo, A., Grande, L., Ruiz-Ontañón, P., Velásquez, C., Mollinedo, P., Torices, S., Sánchez‐Gómez, P., Aznar, A. B., Esparís-Ogando, A., López, C., et al. (2016) · Oncogene · doi:10.1038/onc.2016.341 · Cited by 54
Self-citationAtorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression
Yi, Y., Shuyun, H., Lei, C., Xiangrong, C., Zhilin, Y., & Yiquan, K. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.04.020 · Cited by 53
Nguyen, K. T., Zong, C. S., Uttamsingh, S., Sachdev, P., Bhanot, M., Le, M. N., Chan, J. L. ‐., & Wang, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108166200 · Cited by 53
Karpel‐Massler, G., Westhoff, M., Zhou, S., Nonnenmacher, L., Dwucet, A., Kast, R. E., Bachem, M. G., Wirtz, C. R., Debatin, K., & Halatsch, M. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0052 · Cited by 53
Golgi-associated RhoBTB3 targets Cyclin E for ubiquitylation and promotes cell cycle progression
Lu, A., & Pfeffer, S. R. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201305158 · Cited by 53
Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia
Sanchez-Aguilera, A., Rattmann, I., Drew, D. Z., Müller, L. U. W., Summey, V, Lucas, D. M., Byrd, J. C., Croce, C. M., Gu, Y., Cancelas, J. A., et al. (2010) · Leukemia · doi:10.1038/leu.2009.217 · Cited by 52
Zohar, M., Teramoto, H., Katz, B., Yamada, K. M., & Gutkind, J. S. (1998) · Oncogene · doi:10.1038/sj.onc.1202022 · Cited by 52
Karasic, T. B., Chiorean, E. G., Sebti, S. M., & O'Dwyer, P. J. (2019) · Targeted Oncology · doi:10.1007/s11523-019-00661-5 · Cited by 52
Cdc42 Promotes G1 Progression through p70 S6 Kinase-mediated Induction of Cyclin E Expression
Chou, M. M., Robens, J., & Gupta, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305246200 · Cited by 51
ras gene Amplification and Malignant Transformation
Pulciani, S., Santos, E., Long, L. K., Sorrentino, V., & Barbacid, M. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.10.2836-2841.1985 · Cited by 51
RhoA Silencing Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells
Doublier, S., Riganti, C., Voena, C., Costamagna, C., Aldieri, E., Pescarmona, G., Ghigo, D., & Bosìa, A. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0251 · Cited by 50
Active contractility at E-cadherin junctions and its implications for cell extrusion in cancer
Wu, S. K., Lagendijk, A. K., Hogan, B. M., Gomez, G. A., & Yap, A. S. (2015) · Cell Cycle · doi:10.4161/15384101.2014.989127 · Cited by 50
Generation of rac3 Null Mutant Mice: Role of Rac3 in Bcr/Abl-Caused Lymphoblastic Leukemia
Cho, Y. J., Zhang, B., Kaartinen, V., Haataja, L., de Curtis, I., Groffen, J., & Heisterkamp, N. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5777-5785.2005 · Cited by 50
Ladhani, O., Sánchez-Martínez, C., Orgaz, J. L., Jiménez, B., & Volpert, O. V. (2011) · Neoplasia · doi:10.1593/neo.11446 · Cited by 48
Self-citationMar, V., Wong, S. Q., Logan, A., Nguyen, T. V., Cebon, J. S., Kelly, J. W., Wolfe, R. S., Dobrovic, A., McLean, C., & McArthur, G. A. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12295 · Cited by 48
Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer
Unbekandt, M., Belshaw, S., Bower, J. F., Clarke, M., Cordes, J., Crighton, D., Croft, D. R., Drysdale, M. J., Garnett, M. J., Gill, K., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2870 · Cited by 48
Yuzugullu, H., Baitsch, L., Von, T., Steiner, A., Tong, H., Ni, J., Clayton, L. K., Bronson, R., Roberts, T. M., Gritsman, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms9501 · Cited by 47
STAT3-coordinated migration facilitates the dissemination of diffuse large B-cell lymphomas
Pan, Y.-R., Chen, C.-C., Chan, Y.-T., Wang, H.-J., Chien, F.-T., Chen, Y.-L., Liu, J.-L., & Yang, M.-H. (2018) · Nature Communications · doi:10.1038/s41467-018-06134-z · Cited by 47
Takahashi, N., Nobusue, H., Shimizu, T., Sugihara, E., Yamaguchi‐Iwai, S., Onishi, N., Kunitomi, H., Kuroda, T., & Saya, H. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2693 · Cited by 47
Zhang, B., Zhang, Y., & Shacter, E. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5716-5725.2003 · Cited by 46
Novel signatures of cancer‐associated fibroblasts
Bozóky, B., Savchenko, A., Csermely, P., Korcsmáros, T., Dúl, Z., Pontén, F., Székely, L., & Klein, G. (2013) · International Journal of Cancer · doi:10.1002/ijc.28035 · Cited by 46
Pak and Rac GTPases promote oncogenic KIT–induced neoplasms
Martin, H., Mali, R. S., Ma, P., Chatterjee, A., Ramdas, B., Sims, E., Munugalavadla, V., Ghosh, J., Mattingly, R. R., Visconte, V., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67509 · Cited by 45
Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK
Vogel, C., Smit, M. A., Maddalo, G., Possik, P. A., Sparidans, R. W., van der Burg, S. H., Verdegaal, E. M. E., Heck, A. J. R., Samatar, A. A., Beijnen, J. H., et al. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12364 · Cited by 45
Tonozuka, Y., Minoshima, Y., Bao, Y. C., Moon, Y., Tsubono, Y., Hatori, T., Nakajima, H., Nosaka, T., Kawashima, T., & Kitamura, T. (2004) · Blood · doi:10.1182/blood-2004-03-1066 · Cited by 44
Morin, P., Flors, C., & Olson, M. F. (2009) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2009.04.005 · Cited by 44
RhoBTB2 (DBC2) Is a Mitotic E2F1 Target Gene with a Novel Role in Apoptosis
Freeman, S. N., Ma, Y., & Cress, W. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705986200 · Cited by 44
Rac3 Regulates Cell Invasion, Migration and EMT in Lung Adenocarcinoma through p38 MAPK Pathway
Zhang, C., Liu, T., Wang, G., Wang, H., Che, X., Gao, X., & Liu, H. (2017) · Journal of Cancer · doi:10.7150/jca.18161 · Cited by 44
The Rac3 GTPase in Neuronal Development, Neurodevelopmental Disorders, and Cancer
de Curtis, I. (2019) · Cells · doi:10.3390/cells8091063 · Cited by 44
Lorenzo‐Martín, L. F., Fernández-Parejo, N., Menacho-Márquez, M., Rodríguez‐Fdez, S., Robles‐Valero, J., Zumalave, S., Fabbiano, S., Pascual, G., Garcia-Pedrero, J. M., Abad, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18524-3 · Cited by 44
Chaudhry, S. I., Hooper, S., Nye, E., Williamson, P., Harrington, K., & Sahai, E. (2013) · Oncogene · doi:10.1038/onc.2012.91 · Cited by 43
Molnár, J., Fazakas, C., Haskó, J., Sipos, O., Nagy, K. S., Nyúl‐Tóth, Á., Farkas, A. E., Végh, A. G., Váró, G., Galajda, P., et al. (2015) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1122156 · Cited by 43
RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinoma
Ma, W., Sze, K. M., Chan, L., Lee, J. M., Wei, L. L., Wong, C., Lee, T. K., Wong, C. C., & Ng, I. O. (2016) · Oncotarget · doi:10.18632/oncotarget.9441 · Cited by 43
Extent of Cell Confinement in Microtracks Affects Speed and Results in Differential Matrix Strains
Mosier, J. A., Rahman-Zaman, A., Zanotelli, M. R., VanderBurgh, J. A., Bordeleau, F., Hoffman, B. D., & Reinhart‐King, C. A. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2019.09.024 · Cited by 43
ROCK Inhibition Facilitates In Vitro Expansion of Glioblastoma Stem-Like Cells
Tilson, S. G., Haley, E. M., Triantafillu, U. L., Dozier, D. A., Langford, C. P., Gillespie, G. Y., & Kim, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132823 · Cited by 42
RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho
Barone, M. V., Sepe, L., Melillo, R. M., Mineo, A., Santelli, G., Monaco, C., Castellone, M. D., Tramontano, D., Fusco, A., & Santoro, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204886 · Cited by 42
Li, J., & Smithgall, T. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13828 · Cited by 42
Wang, Y., Gratzke, C., Tamalunas, A. J., Nicolas, W., Ciotkowska, A., Rutz, B., Waidelich, R. M., Strittmatter, F., Liu, C., Stief, C. G., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153312 · Cited by 42
Hampsch, R. A., Shee, K., Bates, D. J. P., Lewis, L. D., Désiré, L., Leblond, B., Demidenko, E., Stefan, K., Huang, Y. H., & Miller, T. W. (2017) · Oncotarget · doi:10.18632/oncotarget.15586 · Cited by 42
Deng, X., Tu, Z., Xiong, M., Tembo, K. M., Zhou, L., Liu, P., Pan, S., Xiong, J., Yang, X., Leng, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16559 · Cited by 42
Meng, F., Su, Y., & Xu, B. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12804 · Cited by 42
Samuel, M. S., Lourenço, F. C., & Olson, M. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017143 · Cited by 41
Fluvastatin inhibits growth and alters the malignant phenotype of the C6 glioma cell line
Sławińska-Brych, A., Zdzisińska, B., & Kandefer‐Szerszeń, M. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.01.002 · Cited by 41
Tagalakis, A. D., Madaan, S., Larsen, S. D., Neubig, R. R., Khaw, P. T., Rodrigues, I. A. S., Goyal, S., Lim, K. S., & Yu‐Wai‐Man, C. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0425-3 · Cited by 41
The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation
Sahay, S., Pannucci, N. L., Mahon, G. M., Rodriguez, P. L., Megjugorac, N. J., Kostenko, E. V., Ozer, H. L., & Whitehead, I. P. (2007) · Oncogene · doi:10.1038/sj.onc.1210841 · Cited by 39
Rebalancing of actomyosin contractility enables mammary tumor formation upon loss of E-cadherin
Schipper, K., Seinstra, D., Drenth, A. P., van der Burg, E., Ramovš, V., Sonnenberg, A., van Rheenen, J., Nethe, M., & Jonkers, J. (2019) · Nature Communications · doi:10.1038/s41467-019-11716-6 · Cited by 39
The involvement of mutant Rac1 in the formation of invadopodia in cultured melanoma cells
Revach, O., Winograd-Katz, S. E., Samuels, Y., & Geiger, B. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.02.003 · Cited by 38
Al-Haidari, A. A., Syk, I., & Thorlacius, H. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.078 · Cited by 36
Loss of RhoA promotes skin tumor formation and invasion by upregulation of RhoB
Mariscal, A. G., Li, H., Pedersen, E., Peyrollier, K., Ryan, K. M., Stanley, A., Quondamatteo, F., & Brakebusch, C. (2017) · Oncogene · doi:10.1038/onc.2017.333 · Cited by 36
Das, K., Prasad, R., Singh, A., Bhattacharya, A., Roy, A., Mallik, S., Mukherjee, A. K., & Sen, P. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22891 · Cited by 36
RhoC Regulates the Proliferation of Gastric Cancer Cells through Interaction with IQGAP1
Wu, Y. R., Tao, Y., Chen, Y., & Xu, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048917 · Cited by 35
Urich, M., Senften, M., Shaw, P. E., & Ballmer‐Hofer, K. (1997) · Oncogene · doi:10.1038/sj.onc.1200982 · Cited by 35
Shi, Y., Bollam, S., White, S. M., Laughlin, S. Z., Graham, G. T., Wadhwa, M., Chen, H., Nguyen, C. D. K., Vitte, J., Giovannini, M., et al. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.09.027 · Cited by 35
Gong, X., Didan, Y., Lock, J. G., & Strömblad, S. (2018) · The EMBO Journal · doi:10.15252/embj.201898994 · Cited by 35
Kim, D. K., Kim, E. K., Jung, D., & Kim, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214553 · Cited by 35
RHO Family GTPases in the Biology of Lymphoma
Voena, C., & Chiarle, R. (2019) · Cells · doi:10.3390/cells8070646 · Cited by 35
Underexpression of RhoH in Hairy Cell Leukemia
Galiègue-Zouitina, S., Delestré, L., Dupont, C., Troussard, X., & Shelley, C. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5661 · Cited by 34
Marques, C. A., Hähnel, P. S., Wölfel, C., Thaler, S., Huber, C., Theobald, M., & Schüler, M. (2007) · Blood · doi:10.1182/blood-2007-05-089458 · Cited by 34
Semenova, G., Степанова, Д. С., Dubyk, C. W., Handorf, E. A., Deyev, S. M., Lazar, A. J., & Chernoff, J. (2017) · Oncogene · doi:10.1038/onc.2017.143 · Cited by 34
Sarrabayrouse, G., Pich-Bavastro, C., Teiti, I., & Tilkin‐Mariame, A. F. (2016) · International Journal of Cancer · doi:10.1002/ijc.30422 · Cited by 33
Gao, L., Nath, S. C., Jiao, X., Zhou, R., Nishikawa, S. G., Krawetz, R. J., Li, X., & Rancourt, D. E. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101641 · Cited by 33
Chatterjee, M., & van Golen, K. L. (2010) · International Journal of Cancer · doi:10.1002/ijc.25655 · Cited by 32
Yang, H.-S., & Hinds, P. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3141 · Cited by 32
Cobellis, G., Missero, C., & Lauro, R. D. (1998) · Oncogene · doi:10.1038/sj.onc.1202130 · Cited by 32
Rac GTPase Activity is Essential for EGF-induced Mitogenesis
Kim, B.-C., Yi, J.-Y., Yi, S.-J., Shin, I.-C., Ha, K., Jhun, B. H., Hwang, S. B., & Kim, J. (1998) · Molecules and Cells · doi:10.1016/s1016-8478(23)13397-8 · Cited by 32
Discovery and characterization of small molecule Rac1 inhibitors
Arnst, J. L., Hein, A. L., Taylor, M., Palermo, N. Y., Contreras, J. I., Sonawane, Y. A., Wahl, A. O., Ouellette, M. M., Natarajan, A., & Yan, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.16656 · Cited by 31
López‐Luque, J., Bertrán, E., Crosas‐Molist, E., Maiques, Ó., Malfettone, A., Caja, L., Serrano, T., Ramos, E., Sanz‐Moreno, V., & Fabregat, I. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.08.011 · Cited by 31
Self-citationEffect of PAK Inhibition on Cell Mechanics Depends on Rac1
Mierke, C. T., Puder, S., Aermes, C., Fischer, T., & Kunschmann, T. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00013 · Cited by 31
Sachdev, P., Jiang, Y., Li, W., Miki, T., Maruta, H., Nur-e-Kamal, M. S. A., & Wang, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010995200 · Cited by 30
Inhibition of Rac controls NPM–ALK-dependent lymphoma development and dissemination
Colomba, A., Giuriato, S., Dejean, E., Thornber, K., Delsol, G., Tronchère, H., Meggetto, F., Payrastre, B., & Gaits‐Iacovoni, F. (2011) · Blood Cancer Journal · doi:10.1038/bcj.2011.19 · Cited by 30
Klein, E. A., Campbell, L. E., Kothapalli, D., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804537200 · Cited by 30
RhoA knockout fibroblasts lose tumor-inhibitory capacity in vitro and promote tumor growth in vivo
Alkasalias, T., Alexeyenko, A., Hennig, K., Danielsson, F., Lebbink, R. J., Fielden, M. L., Turunen, S. P., Lehti, K., Kashuba, V. I., Madapura, H. S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621161114 · Cited by 30
Boerner, J. L., Danielsen, A. J., McManus, M. J., & Maihle, N. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003801200 · Cited by 29
Zhang, X., Machii, T., Matsumura, I., Ezoe, S., Kawasaki, A., Tanaka, H., Ueda, S., Sugahara, H., Shibayama, H., Mizuki, M., et al. (2003) · International Journal of Hematology · doi:10.1007/bf02983784 · Cited by 29
ROCK1 Inhibition Promotes the Self-Renewal of a Novel Mouse Mammary Cancer Stem Cell
Castro, D. J., Maurer, J., Hebbard, L., & Oshima, R. G. (2012) · Stem Cells · doi:10.1002/stem.1224 · Cited by 29
Orlov, D., Ankichetty, S. P., Chung, F. F., & Brull, R. (2013) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2013.02.015 · Cited by 29
Leal, A. S., Misek, S. A., Lisabeth, E. M., Neubig, R. R., & Liby, K. T. (2019) · Scientific Reports · doi:10.1038/s41598-019-43430-0 · Cited by 29
Rac1 gene mutations in human brain tumours
Hwang, S., Hong, Y., Sy, W.-D., Lieu, A., Lin, C., Lee, K.-S., & Howng, S. L. (2003) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2003.10.018 · Cited by 27
Suppression of the p53-Dependent Replicative Senescence Response by Lysophosphatidic Acid Signaling
Kortlever, R. M., Brummelkamp, T. R., van Meeteren, L. A., Moolenaar, W. H., & Bernards, R. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0066 · Cited by 27
Pharmacological Rac1 inhibitors with selective apoptotic activity in human acute leukemic cell lines
Cabrera, M., Echeverría, E., Lenicov, F. R., Cardama, G. A., González, N., Davio, C. A., Fernández, N., & Menna, P. L. (2017) · Oncotarget · doi:10.18632/oncotarget.21533 · Cited by 27
Kapoor, A., Barai, A., Thakur, B. L., Das, A., Patwardhan, S., Monteiro, M., Gaikwad, S. M., Bukhari, A. B., Mogha, P., Majumder, A., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.11.012 · Cited by 27
A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma
Maiques, Ó., Fanshawe, B., Crosas‐Molist, E., Rodríguez‐Hernández, I., Volpe, A., Cantelli, G., Boehme, L., Orgaz, J. L., Mardakheh, F. K., Sanz‐Moreno, V., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01442-6 · Cited by 27
Self-citationRentala, S., Chintala, R., Guda, M., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.112 · Cited by 26
Vav Transformation Requires Activation of Multiple GTPases and Regulation of Gene Expression
Palmby, T. R., Abe, K., Karnoub, A. E., & Der, C. J. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.702.2.12 · Cited by 26
Chen, S., Li, H., Li, S., Yu, J., Wang, M., Xing, H., Tang, K., Tian, Z., Rao, Q., & Wang, J. (2016) · Stem Cells · doi:10.1002/stem.2348 · Cited by 26
The RhoJ-BAD signaling network: An Achilles’ heel for BRAF mutant melanomas
Ruiz, R., Jahid, S., Harris, M. L., Marzese, D. M., Espitia, F., Vasudeva, P., Chen, C., de Feraudy, S. M., Wu, J., Gillen, D. L., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006913 · Cited by 26
Expression of Rac3 in human brain tumors
Hwang, S., Chang, J.-H., Cheng, T.-S., Sy, W.-D., Lieu, A., Lin, C., Lee, K., Howng, S., & Hong, Y. (2005) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2004.08.013 · Cited by 25
Cdc42-mediated supracellular cytoskeleton induced cancer cell migration under low shear stress
Liu, L., Jiang, H., Zhao, W., Meng, Y., Li, J., Huang, T., & Sun, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.08.149 · Cited by 25
Tomino, T., Tajiri, H., Tatsuguchi, T., Shirai, T., Oisaki, K., Matsunaga, S., Sanematsu, F., Sakata, D., Yoshizumi, T., Maehara, Y., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.073 · Cited by 24
Prognostic implication and biological roles of RhoH in acute myeloid leukaemia
Iwasaki, T., Katsumi, A., Kiyoi, H., Tanizaki, R., Ishikawa, Y., Ozeki, K., Kobayashi, M., Abe, A., Matsushita, T., Watanabe, T., et al. (2008) · European Journal of Haematology · doi:10.1111/j.1600-0609.2008.01132.x · Cited by 24
Rac1 targeting suppresses p53 deficiency–mediated lymphomagenesis
Bosco, E. E., Ni, W., Wang, L., Guo, F., Johnson, J. F., & Zheng, Y. (2010) · Blood · doi:10.1182/blood-2009-02-202440 · Cited by 24
Tanji, M., Ishizaki, T., Ebrahimi, S., Tsuboguchi, Y., Sukezane, T., Akagi, T., Frame, M. C., Hashimoto, N., Miyamoto, S., & Narumiya, S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00197-10 · Cited by 24
Yang, X., Hu, F., Liu, J. A., Yu, S., Cheung, M. P. L., Liu, X., Ng, I. O., Guan, X., Wong, K. K. W., Sharma, R., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1274-8 · Cited by 24
RhoD participates in the regulation of cell-cycle progression and centrosome duplication
Kyrkou, A., Soufi, M., Bahtz, R., Ferguson, C., Bai, M., Parton, R. G., Hoffmann, I., Zerial, M., Fotsis, T., & Murphy, C. (2012) · Oncogene · doi:10.1038/onc.2012.195 · Cited by 23
Siekmann, I., Dierck, K., Prall, S., Klokow, M., Strauß, J., Buhs, S., Wrzeszcz, A., Bockmayr, M. L., Beck, F., Trochimiuk, M., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018020693 · Cited by 22
Rho GTPase effectors and NAD metabolism in cancer immune suppression
Chaker, M., Minden, A., Chen, S., Weiss, R. H., Chini, E. N., Mahipal, A., & Azmi, A. S. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1413091 · Cited by 21
Lehman, H. L., Kidacki, M., Warrick, J. I., & Stairs, D. B. (2018) · Oncotarget · doi:10.18632/oncotarget.24358 · Cited by 21
Mitochondrial Dysfunction in Human Leukemic Stem/Progenitor Cells upon Loss of RAC2
Capala, M. E., Maat, H., Bonardi, F., van den Boom, V., Kuipers, J., Vellenga, E., Giepmans, B. N. G., & Schuringa, J. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128585 · Cited by 20
Role of Rho kinases in abnormal and normal hematopoiesis
Mali, R. S., Kapur, S., & Kapur, R. (2014) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000056 · Cited by 20
In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression
Teiti, I., Bertrand, F. A., Pich-Bavastro, C., Gence, R., Lajoie‐Mazenc, I., Rochaix, P., Favre, G., & Tilkin‐Mariamé, A. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00156 · Cited by 19
Xi, Y., Niu, J., Shen, Y., Li, D., Peng, X., & Wu, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.167 · Cited by 19
Mills, S. C., Howell, L. A., Beekman, A. M., Stokes, L., & Müeller, A. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.10.006 · Cited by 19
c‐Met‐dependent phosphorylation of RhoA plays a key role in gastric cancer tumorigenesis
Liu, J., Li, S., Chen, S., Chen, S., Geng, Q., & Xu, D. (2019) · The Journal of Pathology · doi:10.1002/path.5287 · Cited by 19
Wang, K., Huynh, N. T., Wang, X., Pajic, M., Parkin, A., Man, J., Baldwin, G. S., Nikfarjam, M., & He, H. Z. (2019) · Europe PMC (PubMed Central) · Cited by 17
Fischer, R. S., Zheng, Y., & Quinlan, M. P. (1998) · PubMed · Cited by 16
Samuel, M. S., & Olson, M. F. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.07.002 · Cited by 15
Hinterleitner, C., Huelsenbeck, J., Henninger, C., Wartlick, F., Schorr, A., Kaina, B., & Fritz, G. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0842-6 · Cited by 15
Rac is Essential in the Transformation of Endothelial Cells by Polyoma Middle T
Connolly, J. O., Soga, N., Guo, X. L., Alvarez, U., & Hruska, K. A. (2000) · Cell Communication & Adhesion · doi:10.3109/15419060009109022 · Cited by 15
Identification of novel functions of the ROCK2-specific inhibitor KD025 by bioinformatics analysis
Park, J., & Chun, K. (2020) · Gene · doi:10.1016/j.gene.2020.144474 · Cited by 12
van der Weyden, L., Świątkowska, A., Iyer, V., Speak, A. O., & Adams, D. J. (2020) · G3 Genes Genomes Genetics · doi:10.1534/g3.120.401128 · Cited by 9
RhoBTB Proteins Regulate the Hippo Pathway by Antagonizing Ubiquitination of LKB1
Nguyen, T., Ralbovska, A., & Kugler, J. (2020) · G3 Genes Genomes Genetics · doi:10.1534/g3.120.401038 · Cited by 7
(2002) · PubMed
Cited by
Yuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977
Structural Insight into Geranylgeranyl Diphosphate Synthase (GGDPS) for Cancer Therapy
Pham, A. C., Holstein, S. A., & Borgstahl, G. E. O. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0358 · Cited by 9
Metadata
- Authors
- Crosas-Molist, E., Samain, R., Kohlhammer, L., Orgaz, J. L., George, S. L., Maiques, O., Barcelo, J., & Sanz-Moreno, V.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 2022-01-01
- Volume
- 102
- Issue
- 1
- Pages
- 455-510
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W3200317384
- Cited by
- 272
- References
- 537
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.